Results 221 to 230 of about 330,161 (260)
Some of the next articles are maybe not open access.
Progress and challenges in anti-obesity pharmacotherapy
The Lancet Diabetes & Endocrinology, 2018Obesity is a serious and growing worldwide health challenge. Healthy lifestyle choices are the foundation of obesity treatment. However, weight loss can lead to physiological adaptations that promote weight regain. As a result, lifestyle treatment alone typically produces only modest weight loss that is difficult to sustain. In other metabolic diseases,
Bessesen, Daniel H., Van Gaal, Luc F.
openaire +3 more sources
Natural products in anti-obesity therapy
Natural Product Reports, 2011Covering: up to 2011 Obesity is a major health concern of modern times and should be considered a global epidemic. Conventional or allopathic medicines used to treat obesity have high abuse potential and frequently exhibit side effects. Few botanicals included in natural weight loss products have been thoroughly researched on a basic and ...
Ilze, Vermaak +2 more
openaire +2 more sources
Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design, 2003In order to develop an effective pharmacological treatment for obesity, an endogenous factor that promotes a positive energy balance by increasing appetite and decreasing fat oxidation could represent the drug target scientists have been looking for.
Tamas L, Horvath +4 more
openaire +2 more sources
2000
The article contains sections titled: 1. Introduction 2. Animal and Human Test Procedures 3. Mechanism of Action 4. Clinical Side Effects 5. Phenethylamine Derivatives 5.1. β-Phenylisopropylamines 5.2. β-Phenyl-tert-butylamines 5.3. β-Phenyl-β-oxyisopropylamines 5.4. 1-Methyl-2-phenylmorpholines 6. Other Compounds 7. Economic
openaire +1 more source
The article contains sections titled: 1. Introduction 2. Animal and Human Test Procedures 3. Mechanism of Action 4. Clinical Side Effects 5. Phenethylamine Derivatives 5.1. β-Phenylisopropylamines 5.2. β-Phenyl-tert-butylamines 5.3. β-Phenyl-β-oxyisopropylamines 5.4. 1-Methyl-2-phenylmorpholines 6. Other Compounds 7. Economic
openaire +1 more source
Anti‐obesity drugs: to be or not to be?
Obesity Reviews, 2010Dvorak, R.V., Sharma, A.M., Astrup, Arne
openaire +3 more sources
Anti-obesity drug discovery: advances and challenges
Nature Reviews Drug Discovery, 2021Timo D Müller +2 more
exaly
Anti-Obesity Drugs: are They Worth It?
Future Medicinal Chemistry, 2011Mark K, Huntington, Roger A, Shewmake
openaire +2 more sources